Search

everythinglearnresearchcommunity

for

Search:↓

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Finasteride shows promise for female hair loss, but more research needed.

Hydralazine and minoxidil are blood pressure medications that relax blood vessels, with potential side effects like rapid heartbeat and fluid retention, and are used for severe or pregnancy-related hypertension.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Dermatologists can help diagnose endocrine disorders like PCOS and metabolic syndrome by looking at skin symptoms.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

New drugs like clonidine and prazosin show promise for treating high blood pressure despite some side effects.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.